Recently Li et al. reported that TGF-β suppresses Th2 cell-mediated anticancer immunity in an autocrine fashion and that blocking TGF-β signaling in CD4+ T cells inhibited cancer progression (72). The gene discussed is TGFB1; the disease is cancer.